Your contact person
Manager PR & Communications Jan Phillip Denkers
Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint ...
Evotec and Takeda enter collaboration
Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (“Takeda”). Under the collaboration, the parties aim to establish at ...
Eppendorf AG: Positive first half-year 2019
The globally active Eppendorf Group charted a strong first half-year in 2019 with a significant surge in Group sales to €378.5 million (prior year: ...
New IMI project “GNA NOW” kicks off its battle against antimicrobial resistance
Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents: Gram-Negative Antibacterials NOW (“GNA NOW”). The ...
Evotec expands its iPSC discovery platform
Evotec SE announced that the Company has acquired assets from the stem cell specialist Ncardia AG to advance Evotec’s iPSC platform, one of the ...
Evotec and venture capital consortium form "Breakpoint Therapeutics GmbH"
Evotec SE announced the formation of Breakpoint Therapeutics GmbH, a spin-off company focusing on the development of Evotec’s DNA damage response (“DDR”) portfolio, comprising ...
CORNET issues Calls for Proposals
The 28th CORNET Call for Proposals is now OPEN! Submission is possible until 25 September 2019, 12 p.m. (CET) via the Submission Tool. ...
Evotec create a new bridge partnership in digital health
Evotec SE announced that it has entered into a new strategic partnership with the British clinical AI technology company Sensyne Health plc (LSE:SENS) (“Sensyne”), ...
Evotec receives $ 23.8 m grant to join the global fight against tuberculosis
Evotec SE announced that the company has entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens ...
Evotec acuires Just Biotherapeutics
Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m ...
Eppendorf with worldwide setting program
The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg ...
Evotec and Indivumed announce collaboration for colorectal cancer
Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of ...